Multi‐omics analysis suggests enhanced epileptogenesis in the Cornu Ammonis 3 of the pilocarpine model of mesial temporal lobe epilepsy. Issue 2 (10th October 2020)

• Record Type: Journal Article
• Authors: Canto, Amanda M.; Matos, Alexandre H. B.; Godoi, Alexandre B.; Vieira, André S.; Aoyama, Beatriz B.; Rocha, Cristiane S.; Henning, Barbara; Carvalho, Benilton S.; Pascoal, Vinicius D.B.; Veiga, Diogo F. T.; Gilioli, Rovilson; Cendes, Fernando; Lopes‐Cendes, Iscia
• Is Part Of: Hippocampus. Volume 31:Issue 2(2021)
• Page Start: 122
• Page End: 139
• Publication Date: 2020-10-10
• Subjects: hippocampus -- laser‐capture microdissection -- proteomics -- transcriptomics; Hippocampus (Brain) -- Periodicals; 612.825
• DOI: 10.1002/hipo.23268
• Languages: English
• ISSNs: 1050-9631

Abstract

Abstract: Mesial temporal lobe epilepsy (MTLE) is a chronic neurological disorder characterized by the occurrence of seizures, and histopathological abnormalities in the mesial temporal lobe structures, mainly hippocampal sclerosis (HS). We used a multi‐omics approach to determine the profile of transcript and protein expression in the dorsal and ventral hippocampal dentate gyrus (DG) and Cornu Ammonis 3 (CA3) in an animal model of MTLE induced by pilocarpine. We performed label‐free proteomics and RNAseq from laser‐microdissected tissue isolated from pilocarpine‐induced Wistar rats. We divided the DG and CA3 into dorsal and ventral areas and analyzed them separately. We performed a data integration analysis and evaluated enriched signaling pathways, as well as the integrated networks generated based on the gene ontology processes. Our results indicate differences in the transcriptomic and proteomic profiles among the DG and the CA3 subfields of the hippocampus. Moreover, our data suggest that epileptogenesis is enhanced in the CA3 region when compared to the DG, with most abnormalities in transcript and protein levels occurring in the CA3. Furthermore, our results show that the epileptogenesis in the pilocarpine model involves predominantly abnormal regulation of excitatory neuronal mechanisms mediated by N‐methyl D‐aspartate (NMDA) receptors, changes in the serotonin signaling, and neuronal activity controlled by calcium/calmodulin‐dependent protein kinase (CaMK) regulation and leucine‐rich repeat kinase 2 (LRRK2)/WNT signaling pathways.